Exclusive special offer and discount title banner vector image

ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

Asia-Pacific Neurovascular Devices / Interventional Neurology Market by Product (Embolization Devices, Accessory Devices, Revascularization Devices, Thrombectomy Devices, Embolic Protection Devices) Market by Application (Aneurysm, Ischemic Stroke, Stenosis, Arteriovenous Malformation, Other Applications) by Geography

REQUEST CUSTOMIZATION

MARKET OVERVIEW

The Asia-Pacific neurovascular devices/interventional neurology market is estimated to register a CAGR of 5.46% across the forecast years of 2023 to 2032, capturing a revenue share of $1319.77 million by 2032.

The rising awareness about neurovascular interventions, the significant population resulting in a huge patient base for neurovascular diseases, and a surge in the geriatric populace are among the chief factors facilitating the market growth of the region. However, the Asia-Pacific neurovascular devices/interventional neurology market will likely be obstructed by the lack of trained neurosurgeons.

China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific are considered for the Asia-Pacific neurovascular devices/interventional neurology market growth analysis. China, being one of the most populous countries globally, faces a significant burden of neurological disorders, with a considerable number of patients affected. As the geriatric population continues to grow, stroke has emerged as the leading cause of death among the elderly across the nation. With approximately 2 million stroke cases reported nationwide, the Chinese government has taken proactive measures to enhance stroke prevention and treatment techniques, including standardizing procedures for stroke care across the country. Strategic initiatives from key players are also driving developments in the neurovascular field in China. Genesis MedTech Group’s acquisition of Hua Medtech in 2021 is a prime example of companies seeking to expand their business and establish a specialized neurovascular franchise in the country.

In Japan, the growing prevalence of ischemic strokes has spurred significant advancements in neurological studies and treatments. As the country’s population ages, the incidence of neurological disorders has risen, with stroke being a major concern, attributed to cerebral infarctions. Furthermore, stroke stands as the fourth leading cause of mortality and the primary cause of severe disability in Japan. To address these challenges, the country has witnessed notable developments in neurology departments within general hospitals. In addition, as of October 2021, there were over 2,565 general hospitals with dedicated neurology departments, and approximately 36% of all general hospitals had neuropathic internal medicine departments in Japan. These factors, in turn, are set to boost the neurovascular devices/interventional neurology market growth in the Asia-Pacific over the forecast years.

Asia_Pacific_Neurovascular_Devices_Interventional_Neurology_Market

To Know More About This Report, Request a Free Sample Copy

The Asia-Pacific neurovascular devices/interventional neurology market is segmented into product and application. The application segment includes aneurysm, ischemic stroke, stenosis, arteriovenous malformation (AVM), and other applications.

An aneurysm, also known as the ballooning of blood vessels, is a medical condition characterized by a weak area in a blood vessel that gradually enlarges under the pressure of constant blood flow. Apart from the pressure-related causes, aneurysms can also result from various blood vessel disorders, including cerebral arteritis and fibromuscular dysplasia. Additionally, factors such as infections and the use of drugs like amphetamines and cocaine can contribute to aneurysm development. Furthermore, direct brain trauma from accidents can also lead to the formation of aneurysms.

Some of the major players operating in the Asia-Pacific neurovascular devices/interventional neurology market are Kaneka Corporation, Terumo Corporation, etc.

Terumo Corporation, headquartered in Japan, manufactures and distributes medical products as well as equipment and operates across three major business segments. These include Interventional systems, medical products, and pharmaceutical solutions. The interventional systems segment offers lesion access, minimally invasive entry site management, and interventional technologies such as balloons, stents, sheaths, and others.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Product and Application
Countries AnalyzedChina, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
Companies AnalyzedAcandis GmbH, Asahi Intecc, B Braun Melsungen AG, Balt, Integer Holdings Corporation, Johnson & Johnson (Cerenovus), Kaneka Corporation, Medtronic Inc, Memry Corporation, MicroPort Scientific Corporation, Penumbra Inc, Phenox Inc, Rapid Medical, Stryker Corporation, Terumo Corporation, Sensome

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
    5. MAJOR MARKET FINDINGS
      1. GOVERNMENT INITIATIVES TO CREATE AWARENESS ABOUT NEUROVASCULAR DISEASES
      2. EARLY DETECTION OF ARTERIOVENOUS MALFORMATION (AVM)
      3. THROMBECTOMY IMPROVES PATIENT OUTCOMES AND REDUCES DISABILITY RATE
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. SIGNIFICANT RISE IN INCIDENCE OF NEUROVASCULAR CONDITIONS 
      2. PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
      3. GERIATRIC POPULATION’S VULNERABILITY TO NEUROVASCULAR DISEASES
      4. UNDERLYING DISEASES ARE A RISK FACTOR FOR NEUROVASCULAR DISEASES
    2. KEY RESTRAINTS
      1. EXORBITANT COSTS OF NEUROVASCULAR DEVICES
      2. LACK OF TRAINED NEUROSURGEONS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR THAILAND
    4. MARKET CONCENTRATION ANALYSIS
    5. VALUE CHAIN ANALYSIS
  5. MARKET BY PRODUCT
    1. EMBOLIZATION DEVICES
      1. EMBOLIC COILS
        1. COATED DETACHABLE COILS
        2. BARE DETACHABLE COILS
      2. COIL ASSIST STENT
      3. CLIPPINGS
      4. COIL ASSIST BALLOON
    2. ACCESSORY DEVICES
      1. MICROCATHETERS
      2. MICRO GUIDEWIRES
    3. REVASCULARIZATION DEVICES
      1. CAROTID ARTERY STENTS
      2. FLOW DIVERSION STENTS
    4. THROMBECTOMY DEVICES
      1. CLOT RETRIEVAL DEVICES
      2. SUCTION AND ASPIRATION DEVICES
      3. SNARES
    5. EMBOLIC PROTECTION DEVICES
      1. BALLOON OCCLUSION DEVICES
      2. DISTAL FILTER DEVICES
  6. MARKET BY APPLICATION
    1. ANEURYSM
    2. ISCHEMIC STROKE
    3. STENOSIS
    4. ARTERIOVENOUS MALFORMATION (AVM)
    5. OTHER APPLICATIONS
  7. GEOGRAPHICAL ANALYSIS
    1. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
      3. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
      4. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
      6. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        5. INDONESIA
          1. INDONESIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        6. THAILAND
          1. THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        7. VIETNAM
          1. VIETNAM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        8. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        9. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
  8. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. ACANDIS GMBH
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      2. ASAHI INTECC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
      3. BALT
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      4. B BRAUN MELSUNGEN AG
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      5. INTEGER HOLDINGS CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      6. JOHNSON & JOHNSON (CERENOVUS)
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      7. KANEKA CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      8. MEDTRONIC INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      9. MEMRY CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      10. MICROPORT SCIENTIFIC CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      11. PENUMBRA INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      12. PHENOX INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      13. RAPID MEDICAL
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      14. SENSOME
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      15. STRYKER CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      16. TERUMO CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY

TABLE 2: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 4: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 12: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 14: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 16: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 18: ASIA-PACIFIC NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 20: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK

TABLE 21: KEY PLAYERS OPERATING IN ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET

TABLE 22: LIST OF MERGERS & ACQUISITIONS

TABLE 23: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 24: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 25: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR THAILAND

FIGURE 4: MARKET CONCENTRATION ANALYSIS

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022

FIGURE 7: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIZATION DEVICES, IN 2022

FIGURE 9: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC COILS, 2023-2032 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC COILS, IN 2022

FIGURE 11: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COATED DETACHABLE COILS, 2023-2032 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY BARE DETACHABLE COILS, 2023-2032 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST STENT, 2023-2032 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLIPPINGS, 2023-2032 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST BALLOON, 2023-2032 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY ACCESSORY DEVICES, IN 2022

FIGURE 18: ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET, BY MICROCATHETERS, 2023-2032 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET, BY MICRO GUIDEWIRES, 2023-2032 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY REVASCULARIZATION DEVICES, IN 2022

FIGURE 22: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CAROTID ARTERY STENTS, 2023-2032 (IN $ MILLION)

FIGURE 23: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY FLOW DIVERSION STENTS, 2023-2032 (IN $ MILLION)

FIGURE 24: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 25: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY THROMBECTOMY DEVICES, IN 2022

FIGURE 26: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLOT RETRIEVAL DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 27: ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET, BY SUCTION AND ASPIRATION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 28: ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET, BY SNARES, 2023-2032 (IN $ MILLION)

FIGURE 29: ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 30: ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC PROTECTION DEVICES, IN 2022

FIGURE 31: ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET, BY BALLOON OCCLUSION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 32: ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET, BY DISTAL FILTER DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 33: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022

FIGURE 34: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ANEURYSM, 2023-2032 (IN $ MILLION)

FIGURE 35: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ISCHEMIC STROKE, 2023-2032 (IN $ MILLION)

FIGURE 36: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY STENOSIS, 2023-2032 (IN $ MILLION)

FIGURE 37: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2023-2032 (IN $ MILLION)

FIGURE 38: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY OTHER APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 39: ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 40: CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 41: JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 42: INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 43: SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 44: INDONESIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 45: THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 46: VIETNAM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 47: AUSTRALIA & NEW ZEALAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 48: REST OF ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FAQ’s

Request Customization
Request Customization
Request free sample